News Story: Full Text
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

Nate Brundage continues the fight against brain cancer

Al's Comment:

 This patient's insurance company initially rejected the claim for Optune because of the patient's age.  The FDA approval was for ages 22 and up.   That is a strange age for them to pick. I assume it was because the youngest patient in the trial must have been 22 even though the trial accepted patients 18 and older. Anyway - I am happy the insurance company backed down and approved it.   If anyone else has this problem, contact me and I can try to help fight it.


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://www.wgrz.com/entertainment/television/programs/daybreak/nate-brundage-continues-the-fight-against-brain-cancer/157469597


(Everything below this line is from VirtualTrials.com!)

Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740